FDA Recall Terminated

ImmunoCAP Allergen c6, Amoxicilloyl ( Article number 14-4451-016). ImmunoCAP Specific IgE is an in vitro quantitative assay for the measurement of allergen specific IgE in human serum or plasma; to be used with the instrument Phadia 250, Phadia 1000, Phadia 2500 and Phadia 5000.

Recall: Z-1313-2018 · Initiated December 18, 2017

Recall

Recall Number
Z-1313-2018
Event Number
79444
Firm
Phadia US Inc
FEI Number
3004973408
Product Code
DHB
Status
Terminated
Root Cause
Device Design
Initiated
December 18, 2017
Terminated
March 27, 2019
Address
4169 Commercial Ave, Portage, MI, 49002-9701

Description

ImmunoCAP Allergen c6, Amoxicilloyl ( Article number 14-4451-016). ImmunoCAP Specific IgE is an in vitro quantitative assay for the measurement of allergen specific IgE in human serum or plasma; to be used with the instrument Phadia 250, Phadia 1000, Phadia 2500 and Phadia 5000.

Reason

The stability specifications of ImmunoCAP Allergen c6, Amoxicilloyl were not met.

Action

Customers are being asked to please stop using all current product, and scrap any unused products. Please disregard any reported test result below the assay Limit of Quantification (LoQ 0.1 kUA/l) from the lots, as these results may not be valid. Please note that assay results above the Limit of Quantification, will only be affected by giving a lower result than the real value. Please fill in the Recall Letter Acknowledgement Form provided, including the table in the response form to obtain credit, and return the signed response by e-mail or fax.

Distribution

Nationwide Distribution

Quantity

950 total